Category: Antibody Technologies
Antibody Technologies market research reports by GlobalData
-
Innovation Insights: Antibody-drug conjugates
Innovation Insights: Antibody-drug conjugates Summary Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the cytotoxic effects of chemotherapy drugs. The antibodies are designed to target specific antigens on cancer cells ... Read More
-
Innovation Insights: Targeted Delivery of Oligos to Kidney/Heart
Innovation Insights: Targeted Delivery of Oligos to Kidney/Heart Summary Targeted Delivery of Oligonucleotides explores the innovative strategies and technologies used to deliver oligonucleotides to specific cells or tissues in the body. Oligonucleotides are short DNA or RNA molecules that have the ... Read More
-
Innovation Insights: AI in antibody/biologics discovery
Innovation Insights: AI in antibody/biologics discovery Summary The application of AI and ML technologies for biologics screening is a high-impact innovation with strong commercial activity, including acquisitions and partnerships among key players. Patenting activity in this area has been consisten ... Read More
-
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis Summary This report covers the 8 major markets and provides an Excel-based forecast model for the Alzheimer’s Disease market through 2033. GlobalData estimates that the value of the Alzheimer’s Disease (AD) market in the 8MM in 2023 ... Read More
-
Innovation Insights: Engineered Multispecific antibodies
Innovation Insights: Engineered Multispecific antibodies Summary Engineered multispecific antibodies (MsAbs) are innovative therapeutic molecules designed to bind simultaneously to multiple epitopes on the same or different targets. This capability allows them to address complex diseases more effect ... Read More
-
Innovation Insights: B-cell Depletion
Innovation Insights: B-cell Depletion Summary B cell depletion is a therapeutic strategy aimed at reducing the number of B lymphocytes, which play a crucial role in autoimmune diseases and certain cancers. This approach is primarily used to treat conditions like rheumatoid arthritis, multiple sclero ... Read More
-
Antibody-Drug Conjugates (ADC): Market Overview
Antibody-Drug Conjugates (ADC): Market Overview Summary Clients will gain insight into the competitive landscape of leading antibody-drug conjugates (ADC) in oncology including SWOT analysis for key marketed and pipeline drugs, clinical benchmark comparisons, key clinical trial analysis, analyst con ... Read More
-
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and K ... Read More
-
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast ... Read More
Research Assistance
